These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35623484)

  • 1. Multiplexed electrospray enables high throughput production of cGAMP microparticles to serve as an adjuvant for a broadly acting influenza vaccine.
    Batty CJ; Gallovic MD; Williams J; Ross TM; Bachelder EM; Ainslie KM
    Int J Pharm; 2022 Jun; 622():121839. PubMed ID: 35623484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicits protective immune responses against influenza viruses.
    Zhang X; Shi H; Hendy DA; Bachelder EM; Ainslie KM; Ross TM
    mSphere; 2024 Jul; 9(7):e0016024. PubMed ID: 38920382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained delivery of CpG oligodeoxynucleotide by acetalated dextran microparticles augments effector response to Computationally Optimized Broadly Reactive Antigen (COBRA) influenza hemagglutinin.
    Batty CJ; Amouzougan EA; A Carlock M; Ross TM; Bachelder EM; Ainslie KM
    Int J Pharm; 2023 Jan; 630():122429. PubMed ID: 36436743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicit protective immune responses against influenza viruses.
    Zhang X; Shi H; Hendy DA; Bachelder EM; Ainslie KM; Ross TM
    bioRxiv; 2024 Feb; ():. PubMed ID: 38464191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of acetalated-dextran microparticle fabrication methods for a clinically translatable subunit-based influenza vaccine.
    Pena ES; Batty CJ; Hendy DA; Yang S; Ontiveros-Padilla L; Stiepel RT; Ting JP; Ainslie KM; Bachelder EM
    Int J Pharm; 2024 Mar; 652():123836. PubMed ID: 38266940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vinyl Sulfone-functionalized Acetalated Dextran Microparticles as a Subunit Broadly Acting Influenza Vaccine.
    Batty CJ; Lifshits LM; Hendy DA; Eckshtain-Levi M; Ontiveros-Padilla LA; Carlock MA; Ross TM; Bachelder EM; Ainslie KM
    AAPS J; 2023 Jan; 25(1):22. PubMed ID: 36720729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an Intranasal Gel for the Delivery of a Broadly Acting Subunit Influenza Vaccine.
    Varma DM; Batty CJ; Stiepel RT; Graham-Gurysh EG; Roque JA; Pena ES; Hasan Zahid MS; Qiu K; Anselmo A; Hill DB; Ross TM; Bachelder EM; Ainslie KM
    ACS Biomater Sci Eng; 2022 Apr; 8(4):1573-1582. PubMed ID: 35353486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists.
    Collier MA; Junkins RD; Gallovic MD; Johnson BM; Johnson MM; Macintyre AN; Sempowski GD; Bachelder EM; Ting JP; Ainslie KM
    Mol Pharm; 2018 Nov; 15(11):4933-4946. PubMed ID: 30281314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of tunable acetalated dextran microparticle platform to optimize M2e-based influenza vaccine efficacy.
    Chen N; Gallovic MD; Tiet P; Ting JP; Ainslie KM; Bachelder EM
    J Control Release; 2018 Nov; 289():114-124. PubMed ID: 30261204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses.
    Carter DM; Darby CA; Lefoley BC; Crevar CJ; Alefantis T; Oomen R; Anderson SF; Strugnell T; Cortés-Garcia G; Vogel TU; Parrington M; Kleanthous H; Ross TM
    J Virol; 2016 May; 90(9):4720-4734. PubMed ID: 26912624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STING agonist-containing microparticles improve seasonal influenza vaccine efficacy and durability in ferrets over standard adjuvant.
    Gallovic MD; Junkins RD; Sandor AM; Pena ES; Sample CJ; Mason AK; Arwood LC; Sahm RA; Bachelder EM; Ainslie KM; Sempowski GD; Ting JP
    J Control Release; 2022 Jul; 347():356-368. PubMed ID: 35569585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.
    Allen JD; Ross TM
    J Virol; 2022 Apr; 96(7):e0165221. PubMed ID: 35289635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges.
    Reneer ZB; Jamieson PJ; Skarlupka AL; Huang Y; Ross TM
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination.
    Junkins RD; Gallovic MD; Johnson BM; Collier MA; Watkins-Schulz R; Cheng N; David CN; McGee CE; Sempowski GD; Shterev I; McKinnon K; Bachelder EM; Ainslie KM; Ting JP
    J Control Release; 2018 Jan; 270():1-13. PubMed ID: 29170142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies.
    Huang Y; Owino SO; Crevar CJ; Carter DM; Ross TM
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric cGAMP microparticles affect the immunogenicity of a broadly active influenza mRNA lipid nanoparticle vaccine.
    Hendy DA; Ma Y; Dixon TA; Murphy CT; Pena ES; Carlock MA; Ross TM; Bachelder EM; Ainslie KM; Fenton OS
    J Control Release; 2024 Aug; 372():168-175. PubMed ID: 38844178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mastoparan-7 adjuvanted COBRA H1 and H3 hemagglutinin influenza vaccines.
    Sanchez PL; Staats HF; Abraham SN; Ross TM
    Sci Rep; 2024 Jun; 14(1):13800. PubMed ID: 38877101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses.
    Carter DM; Darby CA; Johnson SK; Carlock MA; Kirchenbaum GA; Allen JD; Vogel TU; Delagrave S; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.